Impact of montelukast on symptoms in mild-to-moderate persistent asthma and exercise-induced asthma: Results of the ASTHMA survey

Current Medical Research and Opinion

Volumn 18, Issue 8, 2002, Pages 512-519

  Malonne, Hugues ^a   Lachman, Albert ^b   Den Brande, Paul Van ^c  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b Centre Hospitalier Moliere Longchamp   (Belgium)

^c Campus Duffel ^*  (Belgium)

Author keywords

Antileukotriene; Asthma; Montelukast

Indexed keywords

ACETYLCYSTEINE; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROMHEXINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; THEOPHYLLINE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG MECHANISM; EVALUATION; EXERCISE INDUCED ASTHMA; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; RECEPTOR BINDING; SLEEP DISORDER; STEROID THERAPY; SYMPTOMATOLOGY;

ACETATES; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; BELGIUM; CHILD; DATA COLLECTION; EXERCISE; FEMALE; HUMANS; MALE; PATIENT SATISFACTION; PHYSICIANS, FAMILY; QUINOLINES;

EID: 0036968599     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001326     Document Type: Article

References (18)

1. Global strategy for asthma management and prevention workshop report. 02-3659. 2002. Bethesda, National Heart, Lung, and Blood Institute (National Institutes of Health)
2. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16(5):802-7
3. Price D, Ryan D, Pearce L, Bride F. The AIR study: Asthma in real life. Asthma J 1999;4(2):74-8
4. Holgate ST. The cellular and mediator basis of asthma in relation to natural history. Lancet 1997;350 (Suppl 2):S115-9
5. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149(4 Pt 1):953-9
6. Pavord ID, Ward R, Woltmann G, Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999; 160(6):1905-9
7. Hay DW, Torphy TJ, Undem BJ. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 1995;16(9):304-9
8. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med 1999;160(6):1862-8
9. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids. Chest 2001;119(4):1021-6
10. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, et al. Adding montelukast is at least as efficacious as doubling the budesonide dose in persistent asthma: results of the compact study. A95 Poster 104. 2002. Atlanta, 98th International Conference of the American Thoracic Society
11. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med 1998;158(11):1213-20
12. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98(6 Pt 1):1051-7
13. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154(12):1349-52
14. Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, et al. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin Exp Allergy 2001;31(6):845-54
15. Bender B, Milgrom H, Rand C, Ackerson L. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1998;35(4):347-53
16. Maspero JF, Duenas-Meza E, Volovitz B, Pinacho DC, Kosa L, Vrijens F, et al. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin 2001;17(2):96-104
17. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000;117(2):542-50
18. Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002;32(7):1020-8